AbSorber's Test Identifies Patients With Increased Risk For Kidney Transplant Rejection

 23.08.2008 10:31   medicalnewstoday.com

LinkMed's (STO:LMED) portfolio company AbSorber recently received FDA approval in the U.S. for its patented transplantation test XM-ONE®. Now AbSorber has received further support for its transplantation test from a major clinical trial in which six well-reputed transplantation centers in the U.S. and Sweden participated.

World Transplantation